Non-small cell lung cancer (NSCLC) accounts for 83% of all lung cancer cases with epidermal growth factor receptor (EGFR)-activating mutations frequently found in these tumors (10–15% in Caucasians, 50% in Asians).2 This evidence concerns the gene EGFR and lung carcinoma.